Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.

The global Migraine Headache Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Migraine Headache Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Headache Drugs.

Report Scope

The Migraine Headache Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Migraine Headache Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Migraine Headache Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Migraine Headache Drugs Market Report

Report Metric	Details
Report Name	Migraine Headache Drugs Market
CAGR	5%
Segment by Type	Almotriptan Eletriptan Sumatriptan Rizatriptan Zolmitriptan Naratriptan Frovatriptan Others
Segment by Application	Acute Migraine Common Migraine Classic Migraine Chronic Migraine Other Migraines
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Mylan, Bayer, Amneal Pharmaceuticals, Apotex, Ajanta Pharma, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Migraine Headache Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Migraine Headache Drugs Market report?

Ans: The main players in the Migraine Headache Drugs Market are Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Mylan, Bayer, Amneal Pharmaceuticals, Apotex, Ajanta Pharma, Allergan

What are the Application segmentation covered in the Migraine Headache Drugs Market report?

Ans: The Applications covered in the Migraine Headache Drugs Market report are Acute Migraine, Common Migraine, Classic Migraine, Chronic Migraine, Other Migraines

What are the Type segmentation covered in the Migraine Headache Drugs Market report?

Ans: The Types covered in the Migraine Headache Drugs Market report are Almotriptan, Eletriptan, Sumatriptan, Rizatriptan, Zolmitriptan, Naratriptan, Frovatriptan, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Almotriptan

1.2.3 Eletriptan

1.2.4 Sumatriptan

1.2.5 Rizatriptan

1.2.6 Zolmitriptan

1.2.7 Naratriptan

1.2.8 Frovatriptan

1.2.9 Others

1.3 Market by Application

1.3.1 Global Migraine Headache Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Acute Migraine

1.3.3 Common Migraine

1.3.4 Classic Migraine

1.3.5 Chronic Migraine

1.3.6 Other Migraines

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Migraine Headache Drugs Market Perspective (2019-2030)

2.2 Migraine Headache Drugs Growth Trends by Region

2.2.1 Global Migraine Headache Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Migraine Headache Drugs Historic Market Size by Region (2019-2024)

2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2025-2030)

2.3 Migraine Headache Drugs Market Dynamics

2.3.1 Migraine Headache Drugs Industry Trends

2.3.2 Migraine Headache Drugs Market Drivers

2.3.3 Migraine Headache Drugs Market Challenges

2.3.4 Migraine Headache Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Migraine Headache Drugs Players by Revenue

3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2019-2024)

3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue

3.4 Global Migraine Headache Drugs Market Concentration Ratio

3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2023

3.5 Migraine Headache Drugs Key Players Head office and Area Served

3.6 Key Players Migraine Headache Drugs Product Solution and Service

3.7 Date of Enter into Migraine Headache Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Headache Drugs Breakdown Data by Type

4.1 Global Migraine Headache Drugs Historic Market Size by Type (2019-2024)

4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2025-2030)

5 Migraine Headache Drugs Breakdown Data by Application

5.1 Global Migraine Headache Drugs Historic Market Size by Application (2019-2024)

5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Migraine Headache Drugs Market Size (2019-2030)

6.2 North America Migraine Headache Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Migraine Headache Drugs Market Size by Country (2019-2024)

6.4 North America Migraine Headache Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Migraine Headache Drugs Market Size (2019-2030)

7.2 Europe Migraine Headache Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Migraine Headache Drugs Market Size by Country (2019-2024)

7.4 Europe Migraine Headache Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Migraine Headache Drugs Market Size (2019-2030)

8.2 Asia-Pacific Migraine Headache Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Migraine Headache Drugs Market Size (2019-2030)

9.2 Latin America Migraine Headache Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Migraine Headache Drugs Market Size by Country (2019-2024)

9.4 Latin America Migraine Headache Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Migraine Headache Drugs Market Size (2019-2030)

10.2 Middle East & Africa Migraine Headache Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Migraine Headache Drugs Introduction

11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Migraine Headache Drugs Introduction

11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Detail

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction

11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2019-2024)

11.3.5 Johnson & Johnson Recent Development

11.4 GSK

11.4.1 GSK Company Detail

11.4.2 GSK Business Overview

11.4.3 GSK Migraine Headache Drugs Introduction

11.4.4 GSK Revenue in Migraine Headache Drugs Business (2019-2024)

11.4.5 GSK Recent Development

11.5 Merck

11.5.1 Merck Company Detail

11.5.2 Merck Business Overview

11.5.3 Merck Migraine Headache Drugs Introduction

11.5.4 Merck Revenue in Migraine Headache Drugs Business (2019-2024)

11.5.5 Merck Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Migraine Headache Drugs Introduction

11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2019-2024)

11.6.5 Eli Lilly Recent Development

11.7 Teva

11.7.1 Teva Company Detail

11.7.2 Teva Business Overview

11.7.3 Teva Migraine Headache Drugs Introduction

11.7.4 Teva Revenue in Migraine Headache Drugs Business (2019-2024)

11.7.5 Teva Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Migraine Headache Drugs Introduction

11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Sun Pharma

11.9.1 Sun Pharma Company Detail

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Migraine Headache Drugs Introduction

11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2019-2024)

11.9.5 Sun Pharma Recent Development

11.10 Grunenthal

11.10.1 Grunenthal Company Detail

11.10.2 Grunenthal Business Overview

11.10.3 Grunenthal Migraine Headache Drugs Introduction

11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2019-2024)

11.10.5 Grunenthal Recent Development

11.11 Endo Pharmaceuticals

11.11.1 Endo Pharmaceuticals Company Detail

11.11.2 Endo Pharmaceuticals Business Overview

11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction

11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2019-2024)

11.11.5 Endo Pharmaceuticals Recent Development

11.12 Mylan

11.12.1 Mylan Company Detail

11.12.2 Mylan Business Overview

11.12.3 Mylan Migraine Headache Drugs Introduction

11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2019-2024)

11.12.5 Mylan Recent Development

11.13 Bayer

11.13.1 Bayer Company Detail

11.13.2 Bayer Business Overview

11.13.3 Bayer Migraine Headache Drugs Introduction

11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2019-2024)

11.13.5 Bayer Recent Development

11.14 Amneal Pharmaceuticals

11.14.1 Amneal Pharmaceuticals Company Detail

11.14.2 Amneal Pharmaceuticals Business Overview

11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction

11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2019-2024)

11.14.5 Amneal Pharmaceuticals Recent Development

11.15 Apotex

11.15.1 Apotex Company Detail

11.15.2 Apotex Business Overview

11.15.3 Apotex Migraine Headache Drugs Introduction

11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2019-2024)

11.15.5 Apotex Recent Development

11.16 Ajanta Pharma

11.16.1 Ajanta Pharma Company Detail

11.16.2 Ajanta Pharma Business Overview

11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction

11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2019-2024)

11.16.5 Ajanta Pharma Recent Development

11.17 Allergan

11.17.1 Allergan Company Detail

11.17.2 Allergan Business Overview

11.17.3 Allergan Migraine Headache Drugs Introduction

11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2019-2024)

11.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Amneal Pharmaceuticals

Apotex

Ajanta Pharma

Allergan plc

List of Tables

Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Almotriptan

Table 3. Key Players of Eletriptan

Table 4. Key Players of Sumatriptan

Table 5. Key Players of Rizatriptan

Table 6. Key Players of Zolmitriptan

Table 7. Key Players of Naratriptan

Table 8. Key Players of Frovatriptan

Table 9. Key Players of Others

Table 10. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Migraine Headache Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Migraine Headache Drugs Market Share by Region (2019-2024)

Table 14. Global Migraine Headache Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Migraine Headache Drugs Market Share by Region (2025-2030)

Table 16. Migraine Headache Drugs Market Trends

Table 17. Migraine Headache Drugs Market Drivers

Table 18. Migraine Headache Drugs Market Challenges

Table 19. Migraine Headache Drugs Market Restraints

Table 20. Global Migraine Headache Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Migraine Headache Drugs Market Share by Players (2019-2024)

Table 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2023)

Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Migraine Headache Drugs Product Solution and Service

Table 27. Date of Enter into Migraine Headache Drugs Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Migraine Headache Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2019-2024)

Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2025-2030)

Table 33. Global Migraine Headache Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Migraine Headache Drugs Revenue Market Share by Application (2019-2024)

Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Migraine Headache Drugs Revenue Market Share by Application (2025-2030)

Table 37. North America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Migraine Headache Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Migraine Headache Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Migraine Headache Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Migraine Headache Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Migraine Headache Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Migraine Headache Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Migraine Headache Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Migraine Headache Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Migraine Headache Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Migraine Headache Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Migraine Headache Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 52. Pfizer Company Detail

Table 53. Pfizer Business Overview

Table 54. Pfizer Migraine Headache Drugs Product

Table 55. Pfizer Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 56. Pfizer Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Migraine Headache Drugs Product

Table 60. Novartis Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Johnson & Johnson Company Detail

Table 63. Johnson & Johnson Business Overview

Table 64. Johnson & Johnson Migraine Headache Drugs Product

Table 65. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 66. Johnson & Johnson Recent Development

Table 67. GSK Company Detail

Table 68. GSK Business Overview

Table 69. GSK Migraine Headache Drugs Product

Table 70. GSK Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 71. GSK Recent Development

Table 72. Merck Company Detail

Table 73. Merck Business Overview

Table 74. Merck Migraine Headache Drugs Product

Table 75. Merck Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 76. Merck Recent Development

Table 77. Eli Lilly Company Detail

Table 78. Eli Lilly Business Overview

Table 79. Eli Lilly Migraine Headache Drugs Product

Table 80. Eli Lilly Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 81. Eli Lilly Recent Development

Table 82. Teva Company Detail

Table 83. Teva Business Overview

Table 84. Teva Migraine Headache Drugs Product

Table 85. Teva Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 86. Teva Recent Development

Table 87. AstraZeneca Company Detail

Table 88. AstraZeneca Business Overview

Table 89. AstraZeneca Migraine Headache Drugs Product

Table 90. AstraZeneca Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 91. AstraZeneca Recent Development

Table 92. Sun Pharma Company Detail

Table 93. Sun Pharma Business Overview

Table 94. Sun Pharma Migraine Headache Drugs Product

Table 95. Sun Pharma Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 96. Sun Pharma Recent Development

Table 97. Grunenthal Company Detail

Table 98. Grunenthal Business Overview

Table 99. Grunenthal Migraine Headache Drugs Product

Table 100. Grunenthal Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 101. Grunenthal Recent Development

Table 102. Endo Pharmaceuticals Company Detail

Table 103. Endo Pharmaceuticals Business Overview

Table 104. Endo Pharmaceuticals Migraine Headache Drugs Product

Table 105. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 106. Endo Pharmaceuticals Recent Development

Table 107. Mylan Company Detail

Table 108. Mylan Business Overview

Table 109. Mylan Migraine Headache Drugs Product

Table 110. Mylan Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 111. Mylan Recent Development

Table 112. Bayer Company Detail

Table 113. Bayer Business Overview

Table 114. Bayer Migraine Headache Drugs Product

Table 115. Bayer Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 116. Bayer Recent Development

Table 117. Amneal Pharmaceuticals Company Detail

Table 118. Amneal Pharmaceuticals Business Overview

Table 119. Amneal Pharmaceuticals Migraine Headache Drugs Product

Table 120. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 121. Amneal Pharmaceuticals Recent Development

Table 122. Apotex Company Detail

Table 123. Apotex Business Overview

Table 124. Apotex Migraine Headache Drugs Product

Table 125. Apotex Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 126. Apotex Recent Development

Table 127. Ajanta Pharma Company Detail

Table 128. Ajanta Pharma Business Overview

Table 129. Ajanta Pharma Migraine Headache Drugs Product

Table 130. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 131. Ajanta Pharma Recent Development

Table 132. Allergan Company Detail

Table 133. Allergan Business Overview

Table 134. Allergan Migraine Headache Drugs Product

Table 135. Allergan Revenue in Migraine Headache Drugs Business (2019-2024) & (US$ Million)

Table 136. Allergan Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Migraine Headache Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Migraine Headache Drugs Market Share by Type: 2023 VS 2030

Figure 3. Almotriptan Features

Figure 4. Eletriptan Features

Figure 5. Sumatriptan Features

Figure 6. Rizatriptan Features

Figure 7. Zolmitriptan Features

Figure 8. Naratriptan Features

Figure 9. Frovatriptan Features

Figure 10. Others Features

Figure 11. Global Migraine Headache Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Migraine Headache Drugs Market Share by Application: 2023 VS 2030

Figure 13. Acute Migraine Case Studies

Figure 14. Common Migraine Case Studies

Figure 15. Classic Migraine Case Studies

Figure 16. Chronic Migraine Case Studies

Figure 17. Other Migraines Case Studies

Figure 18. Migraine Headache Drugs Report Years Considered

Figure 19. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 20. Global Migraine Headache Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 21. Global Migraine Headache Drugs Market Share by Region: 2023 VS 2030

Figure 22. Global Migraine Headache Drugs Market Share by Players in 2023

Figure 23. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2023)

Figure 24. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2023

Figure 25. North America Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. North America Migraine Headache Drugs Market Share by Country (2019-2030)

Figure 27. United States Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Migraine Headache Drugs Market Share by Country (2019-2030)

Figure 31. Germany Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia-Pacific Migraine Headache Drugs Market Share by Region (2019-2030)

Figure 39. China Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Japan Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Latin America Migraine Headache Drugs Market Share by Country (2019-2030)

Figure 47. Mexico Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Brazil Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Migraine Headache Drugs Market Share by Country (2019-2030)

Figure 51. Turkey Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 56. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 57. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 58. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 59. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 60. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 61. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 62. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 63. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 64. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 66. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 67. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 68. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 69. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions